Carregant...
Recent advances of sorafenib nanoformulations for cancer therapy: Smart nanosystem and combination therapy
Sorafenib, a molecular targeted multi-kinase inhibitor, has received considerable interests in recent years due to its significant profiles of efficacy in cancer therapy. However, poor pharmacokinetic properties such as limited water solubility, rapid elimination and metabolism lead to low bioavaila...
Guardat en:
| Publicat a: | Asian J Pharm Sci |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Shenyang Pharmaceutical University
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8261086/ https://ncbi.nlm.nih.gov/pubmed/34276821 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajps.2020.07.003 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|